Kenneth A. Burry

No ORCID on file · 6 papers in corpus · active 1989-1997

Study types

  • article 6

Condition tags

  • endometriosis 5
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
article 1997
Reply of the Authors
·doi:10.1016/s0015-0282(97)90143-6
article 1997
Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral density
Fertility and Sterility ·doi:10.1016/s0015-0282(97)81432-x

ObjectiveTo assess the efficacy, safety, and effect on bone mineral density of a 3-month course of retreatment with intranasal nafarelin acetate for recurrent symptoms of endometriosis.DesignMulticenter, open-label, nonrandomized clinical t…

article 1995
Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain
Fertility and Sterility ·doi:10.1016/s0015-0282(16)57530-x

ObjectivesTo determine the effectiveness of a 3-month course of nafarelin and, furthermore, to determine the long-term efficacy in patients treated for 3 and 6 months with nafarelin for symptoms associated with endometriosis.DesignDouble-bl…

article 1994
Nafarelin therapy in endometriosis: Long-term effects on bone mineral density
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(94)90136-8

ObjectiveThe study intent was to examine long-term effects on bone mass of 3 or 6 months of nafarelin therapy for endometriosis.Study designWomen with established endometriosis (N = 173) were randomized to receive nafarelin (200 micrograms …

article 1991
Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones
Fertility and Sterility ·doi:10.1016/s0015-0282(16)54590-7

ObjectivePatients with endometriosis were studied to investigate hormonal suppression by the gonadotropin-releasing hormone against nafarelin acetate compared with danazol. We hypothesized that the pattern, time course, and degree of gonado…

article 1989
Metabolic changes during medical treatment of endometriosis: Nafarelin acetate versus danazol
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(89)90870-3

In this double-blind study of changes in plasma lipid and lipoprotein concentrations during 6-month medical treatment of endometriosis, 53 patients were randomly assigned to one of four treatment schedules: danazol, 800 mg/day (n = 10); dan…